Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $391.7700 (-0.07%) ($386.7500 - $400.7450) on Fri. Oct. 5, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.66% (three month average) | RSI | 56 | Latest Price | $391.7700(-0.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.6% a day on average for past five trading days. | Weekly Trend | REGN advances 1.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | Factors Impacting REGN price | REGN will decline at least -0.83% in a week (0% probabilities). VXX(-12%) UUP(-11%) TLT(-7%) VIXM(-4%) DIA(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.83% (StdDev 1.66%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
Resistance Level | $393.5 | 5 Day Moving Average | $396.33(-1.15%) | 10 Day Moving Average | $396.41(-1.17%) | 20 Day Moving Average | $393.5(-0.44%) | To recent high | -4.1% | To recent low | 8.5% | Market Cap | $41.539b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |